Discovery of Orally Bioavailable Ligand Efficient Quinazolindiones as Potent and Selective Tankyrases Inhibitors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery of Orally Bioavailable Ligand Efficient Quinazolindiones as Potent and Selective Tankyrases Inhibitors
Authors
Keywords
-
Journal
ACS Medicinal Chemistry Letters
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2021-05-14
DOI
10.1021/acsmedchemlett.1c00160
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tankyrase inhibitors as antitumor agents: a patent update (2013 – 2020)
- (2021) Chirag C. Mehta et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer
- (2020) Fumiyuki Shirai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors
- (2019) Fumiyuki Shirai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell Lines
- (2017) Douglas W. Thomson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tankyrase Inhibition Causes Reversible Intestinal Toxicity in Mice with a Therapeutic Index < 1
- (2015) Yu Zhong et al. TOXICOLOGIC PATHOLOGY
- Tankyrases: Structure, Function and Therapeutic Implications in Cancer
- (2014) Teemu Haikarainen et al. CURRENT PHARMACEUTICAL DESIGN
- Tankyrase Inhibitors as Therapeutic Targets for Cancer
- (2014) Ahmed Kamal et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Design, Synthesis, Crystallographic Studies, and Preliminary Biological Appraisal of New Substituted Triazolo[4,3-b]pyridazin-8-amine Derivatives as Tankyrase Inhibitors
- (2014) Paride Liscio et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation-Driven Colorectal Tumor Growth
- (2013) T. Lau et al. CANCER RESEARCH
- Tankyrases as drug targets
- (2013) Lari Lehtiö et al. FEBS Journal
- Potent DGAT1 Inhibitors in the Benzimidazole Class with a Pyridyl-oxy-cyclohexanecarboxylic Acid Moiety
- (2013) Shuwen He et al. ACS Medicinal Chemistry Letters
- Tankyrase-targeted therapeutics: expanding opportunities in the PARP family
- (2012) Jenna L. Riffell et al. NATURE REVIEWS DRUG DISCOVERY
- New Mechanisms of Pulmonary Fibrosis
- (2009) Robert M. Strieter et al. CHEST
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
- (2009) Shih-Min A. Huang et al. NATURE
- Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
- (2009) Baozhi Chen et al. Nature Chemical Biology
- Tankyrase function at telomeres, spindle poles, and beyond
- (2007) Susan J. Hsiao et al. BIOCHIMIE
- Cellular and molecular mechanisms of fibrosis
- (2007) TA Wynn JOURNAL OF PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now